Merck KGaA acquires Bangalore-based bioscience company

Global pharma major Merck KGaA has acquired Bangalore Genei (India) Private Ltd by its wholly-owned Indian subsidiary, Merck Specialties Pvt Ltd.

Bangalore Genei (India) Private Ltd (BGIP) founded by Dr Padmanabhan Babu in 1989 and acquired by the leading south India-based chemical major Sanmar Group, Chennai in December 2003. Now Merck bought over from the Sanmar Speciality Chemicals Limited (SSCL). No financial details were disclosed.

By combining BGIP's activities with Merck's existing bioscience business, Merck will become one of the leading bioscience companies in India, a release issued here said.

The Bangalore-based company BGIP specializes in the development, production, marketing and sales of products for proteomic and genomic research. With more than 100 employees, the company generated a total revenue of Rs 20.2 crore in FY 09, the release said.